Thomson Reuters reports slightly higher quarterly revenue
November 6, 2018
Lilly to consider more acquisitions like $1.6 billion Armo buy
November 6, 2018

Lilly lifts earnings forecast as newer drugs provide boost

Eli Lilly and Co topped Wall Street estimates for third-quarter profit on Tuesday and raised its yearly earnings target, led by stronger demand for its newer drugs such as diabetes treatment Trulicity and psoriasis medicine Taltz.

Powered by WPeMatico